FaMotidine AMide IMpurity
Synonym(s):3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]propanamide;3-{{{2-[(Diaminomethylene)amino]thiazol-4-yl}methyl}sulphanyl}propanamide
- CAS NO.：76824-16-3
- Empirical Formula: C8H13N5OS2
- Molecular Weight: 259.35
- MDL number: MFCD27966021
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-04-23 13:52:06
What is FaMotidine AMide IMpurity?
The Uses of FaMotidine AMide IMpurity
Famotidine impurity.
Properties of FaMotidine AMide IMpurity
| Melting point: | >140°C (dec.) |
| Boiling point: | 530.5±60.0 °C(Predicted) |
| Density | 1.63±0.1 g/cm3(Predicted) |
| storage temp. | Hygroscopic, Refrigerator, under inert atmosphere |
| solubility | DMSO (Slightly), Ethanol (Slightly, Sonicated), Methanol (Slightly, Heated, Soni |
| form | neat |
| pka | 16.19±0.40(Predicted) |
| color | White to Pale Yellow |
| Stability: | Hygroscopic |
Safety information for FaMotidine AMide IMpurity
Computed Descriptors for FaMotidine AMide IMpurity
Abamectin manufacturer
GLP Pharma Standards
2Y
Phone:+91-9866074638
Whatsapp: +91 9866074638
product: 76824-16-3 Famotidine EP Impurity-D / Famotidine Related Compound-D 98%
New Products
Tubulysin A Tubulysin F (R)-1-BOC-3-FLUORO PYRROLIDINE 3-Aminocyclobutanone hydrochloride Isoxazole, 3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]thio]-4,5-dihydro-5,5-dimethyl- 4-FLUOROPIPERIDINE HYDROCHLORIDE 4-CYANO-TETRAHYDROPYRAN-4-CARBOXYLIC ACID 4,4-DIFLUOROPIPERIDINE 4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine 3-(7-Nitro-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione ? 4-((1-Cyanocyclobutyl)amino)-2-fluoro-N-methylbenzamide ? (S)-2-Amino-N-((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)-3-phenylpropanamide hydrochloride (R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 3-cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile 7-Methoxyquinoline-4-carboxylic acid 7-Methoxyquinoline-4-carbonitrile 1H-Imidazole-4-carbonitrile (2R,3S)-2-Azido-3-methylpentanoic acid Methyl (2R)-2-amino-3-[(triphenylmethyl)sulfanyl]propanoate (R)-methyl 2-formamido-3-(tritylthio)propanoate (R)-methyl 2-isocyano-3-(tritylthio)propanoate HYDROCORTISONE ACETATE EP IMPURITY E FUSIDIC ACID EP IMPURITY O / FUSIDIC ACID BP IMPURITY O / 16-DEACETYL FUSIDIC ACID SODIUM SALT Montelukast EP Impurity F | Montelukast USP Related Compound ERelated products of tetrahydrofuran
![[3-[[[2-(DiaMinoMethyleneaMino)-4-thiazolyl]Methyl]thio]propionyl]sulfaMide Hydrochloride
(FaMotidine IMpurity)](https://img.chemicalbook.in/CAS/GIF/76824-17-4.gif)
![3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoyl
propanamide](https://img.chemicalbook.in/CAS2/GIF/1020719-36-1.gif)
![Bis[(2-guanidino-4-thiazolyl)methyl]disulfide](https://img.chemicalbook.in/CAS2/GIF/129083-44-9.gif)
![3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamidine](https://img.chemicalbook.in/CAS2/GIF/90237-03-9.gif)
You may like
-
76824-16-3 Famotidine EP Impurity-D / Famotidine Related Compound-D 98%View Details
76824-16-3 -
Famotidine Related Compound D CAS 76824-16-3View Details
76824-16-3 -
3-(4-Methyl-1H-imidazol-1-yl)-5-trifluoromethylanilineView Details
641571-11-1 -
![N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide](https://img.chemicalbook.in//ProductImageIndia/2024-09/Raw/f42956a1-f56e-492d-b262-dc72c437d88e.jpg)
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamideView Details
90357-51-0 -
Ethyl 2-amino-4,5-bis(2-methoxyethoxy)-benzoate HydrochlorideView Details
183322-17-0 -
39856-50-3 5-Bromo-2-nitropyridine 98+View Details
39856-50-3 -
1072-97-5 98+View Details
1072-97-5 -
3-Chloro-4-(pyridin-3-yl)-1,2,5-thiadiazole 98+View Details
131986-28-2
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.